Trp56 of Rac1 specifies interaction with a subset of guanine nucleotide exchange factors

被引:85
作者
Gao, Y
Xing, J
Streuli, M
Leto, TL
Zheng, Y [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA
[2] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[3] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M108865200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling specificity of Rho GTPase pathways is achieved in part by selective interaction between members of the Dbl family guanine nucleotide exchange factors (GEFs) and their Rho GTPase substrates. For example, Trio, GEF-H1, and Tiam1 are a subset of GEFs that specifically activate Rac1 but not the closely related Cdc42. The Rac1 specificity of these GEFs appears to be governed by Rac1-GEF binding interaction. To understand the detailed mechanism underlying the GEF specificity issue, we have analyzed a panel of chimeras made between Rac1 and Cdc42 and examined a series of point mutants of Racl made at the switch I, switch II, and beta (2)/beta (3) regions for their ability to interact with and to be activated by the GEFs. The results reveal that Rac1 residues of both the switch I and switch II regions are involved in GEF docking and GEF-mediated nucleotide disruption, because mutation of Asp(38), Asn(39), Gln(61), Tyr(64), or Arg(66)/Leu(67) into Ala results in the loss of GEF binding, whereas mutation at Tyr(32), Asp(65), or Leu(70)/ Ser(71) leads to the loss of GEF catalysis while retaining the binding capability. The region between amino acids 53-72 of Rac1 is required for specific recognition and activation by the GEFs, and Trp(56) in beta (3), appears to be the critical determinant. Introduction of Trp(56) to Cdc42 renders it fully responsive to the Rac-specific GEF in vitro and in cells. Further, a polypeptide derived from the beta (3) region of Rac1 including the Trp,56 residue serves as a specific inhibitor for Rac1 interaction with the GEFs. Taken together, these results indicate that Trp-56 is the necessary and sufficient determinant of Rac1 for discrimination by the subset of Rac1-specific GEFs and suggest that a compound mimicking Trp 56 action could be explored as an interfering reagent specifically targeting Rac1 activation.
引用
收藏
页码:47530 / 47541
页数:12
相关论文
共 42 条
[1]   Structure and mutagenesis of the Dbl homology domain [J].
Aghazadeh, B ;
Zhu, K ;
Kubiseski, TJ ;
Liu, GA ;
Pawson, T ;
Zheng, Y ;
Rosen, MK .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (12) :1098-1107
[2]   The Drosophila trio plays an essential role in patterning of axons by regulating their directional extension [J].
Awasaki, T ;
Saito, M ;
Sone, M ;
Suzuki, E ;
Sakai, R ;
Ito, K ;
Hama, C .
NEURON, 2000, 26 (01) :119-131
[3]   Ras and Rho GTPases: A family reunion [J].
Bar-Sagi, D ;
Hall, A .
CELL, 2000, 103 (02) :227-238
[4]   The structural basis of the activation of Ras by Sos [J].
Boriack-Sjodin, PA ;
Margarit, SM ;
Bar-Sagi, D ;
Kuriyan, J .
NATURE, 1998, 394 (6691) :337-343
[5]   The Dbl family of oncogenes [J].
Cerione, RA ;
Zheng, Y .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (02) :216-222
[6]   ABR AND BCR ARE MULTIFUNCTIONAL REGULATORS OF THE RHO-GTP-BINDING PROTEIN FAMILY [J].
CHUANG, TH ;
XU, X ;
KAARTINEN, V ;
HEISTERKAMP, N ;
GROFFEN, J ;
BOKOCH, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10282-10286
[7]   Regulation of Tiam1 nucleotide exchange activity by pleckstrin domain binding ligands [J].
Crompton, AM ;
Foley, LH ;
Wood, A ;
Roscoe, W ;
Stokoe, D ;
McCormick, F ;
Symons, M ;
Bollag, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25751-25759
[8]  
De molina AR, 2001, INT J ONCOL, V19, P5
[9]   The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains [J].
Debant, A ;
SerraPages, C ;
Seipel, K ;
OBrien, S ;
Tang, M ;
Park, SH ;
Streuli, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5466-5471
[10]  
Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO